Description of Bromhexine

Bromhexine is an expectorant/mucolytic agent. Bromhexine is not accessible in the United States. It is marketed beneath the barter name Bisolvon(R) in Germany, England, Belgium, France, Italy, Netherlands, Norway, Sweden, Australia, and South Africa.

Bromhexine is a constructed acquired of vasicine that exhibits mucolytic and antioxidative activities. Bromhexine increases assembly of aqueous mucus, decreases fungus viscosity, and helps cilia carriage fungus out of the lungs. Bromhexine is clinically used to amusement respiratory disorders characterized by boundless mucus. Additionally, bromhexine aswell decreases assembly of ROS in alveolar macrophages by modulating enzymatic activity.